Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Colorectal Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Jinjia Chang, PhD) · iamchangjinjia@163.com · 8621-18017317729

Study leads

Wenhua Li, Ph.D
Principal Investigator
Affiliated Cancer Hospital of Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

BRAF V600E · Colorectal Cancer · Sintilimab

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Wuhan, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Metastatic Breast Cancer · Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Cerritos, United States · Los Angeles, United States

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Colorectal Cancer · CRC

Abroad (travel likely)RecruitingPHASE2

Richmond, United States · Richmond, United States